RSV Vaccines: Efficacy in Immunocompromised Older Adults
13 January, 2025
A recent study highlights that older adults with weakened immune systems, particularly organ transplant recipients on immunosuppressive medications, exhibit a weaker and more variable response to respiratory syncytial virus (RSV) vaccines compared to their peers with normal immune function… Read More…